This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
Recent research ties neurological diseases to the coronavirus 2019 (COVID-19) pandemic, a condition that has disrupted our lives and made our planet a different one from December 2019 to today. It is a unique kind of human coronavirus that has been identified as the causative agent of SARS-CoV-2 and has been reported for the first time in Wuhan, China. COVID-19 infection, according to new research, can aggravate the clinical spectrum of exhibited neurological illnesses. Recent studies, on the other hand, have brought the possible significance of this novel coronavirus in the future development of neurological diseases into the forefront, making the neurobiological relationship between these two conditions even more intriguing. Confinement, which may lead to social isolation, is one of the social consequences of the Covid-19's impact on neurodegenerative disorders.
Important Alert:
X
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of